ArticleJournal of cancer research and clinical oncology2016

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.

Christina Schaub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.